Nidan. Good digging. Just fyi, I sent the Alzheimer's Association an email with the announcement by Anavex of the CTAD presentation. Funny, I have sent multiple emails to the association and this is the first time they did not respond back to my email.
Why bother having an important AD conference bend it's agenda rules to accept/allow AVXL to do a piece on PDD results when the Chief FDA executive writes a memo identifying a BIG BREAK relating to AD Cause by another company?
How did AVXL even get on the November 6th conference agenda? Why,... if he (FDA) already had it BALLOON? ready to launch?
None of this makes sense, unless it is just all a politics and money game.